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List of abbreviations 
AHV  Old-age and survivors' insurance 
AHV-HE AHV allowance for the helpless 
AWG  Ageing Working Group of the European Union (Economic Policy Committee and 
European Commission – Directorate General for Economic and Financial 
Affairs) 
DRG   Diagnosis-related groups, i.e. service-related flat rates or flat-rate payments per 
case; the Swiss system of flat-rate payments per case is known as "Swiss 
DRG". 
FDF   Federal Department of Finance 
FFA   Federal Finance Administration, Federal Department of Finance 
FOPH  Federal Office of Public Health, Federal Department of Home Affairs 
FTEs  Full-time equivalents, i.e. the size of a workforce after aggregating those who  
                       work on a part-time basis 
GDP   Gross domestic product 
EL   Supplementary benefits 
ESA  European System of Accounts 
EU  European Union 
FSO   Federal Statistical Office, Federal Department of Home Affairs 
HeL   Healthcare excluding long-term care 
IPR   Individual premium reduction 
IV  Disability insurance 
IV-HE   IV allowance for the helpless 
HIA  Federal Health Insurance Act 
LTC  Long-term care from the age of 65 
Obsan  Swiss Health Observatory 
OECD  Organisation for Economic Co-operation and Development 
OKP   Mandatory health insurance 
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Summary  
 
Healthcare expenditure is currently the equivalent of 11.1% of GDP in Switzerland (2014). This 
proportion has more or less doubled since 1970, putting Switzerland alongside Sweden, 
France, Germany and the Netherlands as one of the highest spenders in this area. One reason 
for this is that healthcare, alongside the cost of retirement provision, is one of the areas most 
heavily affected by demographic ageing.1 An ageing population exhibits greater demand for 
healthcare services, as well having as a greater need for care services.  
 
However, it is not only demographic factors that lie behind the persistent dynamism of 
healthcare expenditure. Equally important are aspects such as advances in medical 
technology, the growing demands of the population as a result of rising incomes, and the 
complexity of the healthcare system, with its many players and the associated incentives to 
increase volumes. As a consequence, the dynamism of expenditure and the associated 
financing burden represent an increasingly important area of focus for economic and financial 
policy-makers.  
 
The expenditure projections for the healthcare system regularly form part of the Report on the 
Long-Term Sustainability of Public Finances (FDF 2016). This Working Paper looks at the 
healthcare issues analysed in that report in greater detail. A key objective of this study is to 
estimate the rise in healthcare expenditure as a result of an ageing Swiss population, together 
with the resulting financing burden for the public finances and mandatory health insurance. In 
addition, we look at the adjustment levers through which healthcare policy-makers can 
influence expenditure development in healthcare. 
 
Projection methodology and scenarios 
The expenditure projections are based on the one hand on the healthcare expenditure profiles, 
which are broken down by age cohort. On the other, they draw on the demographic scenarios 
of the FSO for the period from 2015 to 2045. These demographic scenarios assume a decline 
in fertility, a rise in life expectancy, and an initially high but then declining net immigration rate. 
This makes it possible to capture the consequences of demographic ageing – particularly on 
the part of the baby-boomer generation.  
 
In keeping with the practice of the European Commission (AWG 2015) and the OECD (De la 
Maisonneuve and Oliveira Martins 2014), expenditure for the total healthcare area was 
                                               
1 According to the demographic scenarios of the Federal Statistical Office (FSO), the proportion of people over the 
age of 80 relative to the population as a whole is set to double from the current level of 5% to 10% by 2045. 
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projected under the assumption that the prevailing regulatory status quo will remain unchanged 
("no policy change"). As the cost drivers in healthcare excluding long-term care on the one 
hand and long-term care from the age of 65 on the other are in some cases different, these 
areas are investigated separately. However, in order to ascertain the additional burden for the 
public finances and mandatory health insurance, expenditure projections for the total 
healthcare area have to be made in an initial step. The results of the expenditure projections 
should be interpreted as "if X then Y" hypotheses, rather than forecasts. The projections are 
an extrapolation of long-term trends and their repercussions for healthcare expenditure. 
However, they neither can nor should allow any conclusions to be drawn about the precise 
magnitude of healthcare expenditure in 30 years' time. The objective is rather to provide a 
rough orientation for expenditure development and to highlight how sensitively expenditure 
development reacts to various cost drivers. 
 
In order to illustrate the sensitivity of the projection results, a number of different scenarios 
have been built up. In addition to the immediate repercussions of demographic change, the 
focus is on varying assumptions regarding the change in the general state of health (morbidity 
rate) against a background of rising life expectancy. A further uncertainty factor is the 
development of net immigration. In addition to demographic changes, the effects of key non-
demographic cost drivers will be illustrated. First of all, account will be taken of the correlation 
between national income development and growth in healthcare expenditure. For example, we 
apply the income elasticity on demand-side as well as supply-side effects, such as the 
demands of the population and advances in medical technology. The second factor concerns 
productivity development in healthcare. Lower productivity growth relative to the overall 
economy results in cost pressure if healthcare wages keep step with wage growth in the 
remainder of the economy in the longer term. Given a relatively inelastic demand for healthcare 
services, healthcare prices accordingly rise more strongly than in the remaining economy. This 
so-called "Baumol" effect (Baumol 1967) is considered to be highly significant for the long-term 
care area in particular. 
 
Results of the expenditure projections  
In the "Reference scenario", total healthcare expenditure rises from 10.8% of GDP in the base 
year (2013) to 14.0% of GDP by 2045 (see Table Z1).  
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 * Allowance for the helpless, contributions to medical services and therapeutic equipment. 
** Without participation of the public sector in the form of individual premium reduction, which is assigned to the general 
government sector. 
*** "Other expenditure" includes the expenditure of private households, mandatory accident insurance (SUVA and military 
insurance), as well as supplementary insurance, private foundations, and IV supplementary benefits, which are not affected by 
demographic ageing. 
**** OKP cost contribution and out-of-pocket payments (OOP). 
The remaining category in total healthcare expenditure is expenditure on long-term care below the age of 65. A more detailed 
illustration giving a breakdown of HeL and LTC can be found in Table A2 in the Annex. 
 
Expenditure on long-term care (from the age of 65) rises much more dynamically than 
expenditure on healthcare excluding long-term care. For example, expenditure on long-term 
care rises from 1.6% of GDP to 3.4% of GDP, whereas healthcare expenditure rises from 8.6% 
to 9.9% of GDP. On the one hand, demographic changes (ageing, including the associated 
change in the average state of health) feed through into long-term care to a greater extent 
(72% of the rise in expenditure) than they do into the remaining healthcare area (just under 
60% of the rise in expenditure). On the other, expenditure on long-term care rises by an 
inflation-adjusted 1.2% annually as a result of the Baumol effect, whereas expenditure on 
healthcare rises by just under 0.9% annually as a result of non-demographic cost determinants, 
i.e. rising income per capita.  
 
Public healthcare expenditure 
Expenditure on long-term care is of greater proportional significance to the public finances than 
expenditure on healthcare overall. Accordingly, demographic ageing is of greater significance 
for the public finances than it is for overall healthcare. In the "Reference scenario", public 
Tabelle Z1: Ausgaben des Gesundheitswesens nach Bereichen und Finanzierungsträgern im Referenzszenario (in BIP-%)
Ebene 2013
Gesamtes Gesundheitswesen 10.8 12.2 +1.4 14.0 +3.2
Gesundheit ohne Langzeitpflege 8.6 9.3 +0.7 9.9 +1.3
Langzeitpflege (ab 65 Jahren) 1.6 2.3 +0.7 3.4 +1.8
Finanzierungsträger
Staat (inkl. Sozialwerke) 3.5 4.2 +0.7 5.0 +1.5
Bund 0.4 0.5 +0.1 0.5 +0.1
Kantone 2.4 2.9 +0.5 3.5 +1.1
Gemeinden 0.3 0.4 +0.1 0.5 +0.2
AHV/ IV* 0.4 0.3 -0.0 0.4 +0.0
Obligatorische Krankenpflegeversicherung** 3.3 3.7 +0.4 4.1 +0.8
Restliche Ausgaben*** 4.0 4.3 +0.3 4.8 +0.9
davon: private Haushalte**** 2.6 2.9 +0.3 3.3 +0.7
Niveau
2030 2045
Niveau
Veränderung 
2013-2030
Veränderung 
2013-2045
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expenditure rises from 3.5% of GDP in 2013 to 5% of GDP in 2045 (see Table Z1). This rise 
in expenditure is primarily borne by the cantons. 
 
Public expenditure on healthcare excluding long-term care encompasses expenditure on 
hospitals, individual premium reduction (IPR), and other healthcare expenditure (expenditure 
on prevention, research and development, and administration). The healthcare excluding long-
term care area accounts for 2.4% of GDP of public spending in 2013, and in the "Reference 
scenario" rises to 3.0% of GDP in 2045. The lion's share of the rise in expenditure is attributable 
to contributions to hospitals, which are largely financed by the cantons, and expenditure on 
IPR.  
 
Public expenditure in the area of long-term care comprises the expenditure of the cantons and 
communes on nursing and care homes, as well as outpatient nursing care expenditure 
(Spitex), which meets the costs of caring for people aged 65 or older. Public expenditure on 
long-term care also includes a proportion of cantonal AHV supplementary benefits (EL-AHV) 
and the AHV allowance for the helpless (AHV-HE). General government expenditure on the 
long-term care area amounts to 0.8% of GDP for the base year before doubling to 1.7% of 
GDP by 2045. Both in the area of healthcare generally and in the area of long-term care from 
the age of 65, the cantons currently bear the greatest share of public expenditure on care, 
namely 70%. Accordingly, some two thirds of the increase in public expenditure on the long-
term care area, or 0.6% of GDP, is felt at the cantonal level. The public expenditure of the 
communes is primarily made up of expenditure on long-term care, which doubles as a 
proportion of GDP from 0.2% to 0.4%.  
 
Mandatory health insurance 
In order to avoid overlap with government expenditure, expenditure on mandatory health 
insurance (OKP) is set out in Table Z1 after deduction of IPR expenditure. In addition, the cost 
contributions of private households (deductible, co-payments) have been deducted. Although 
the starting level is at roughly the same level as for public healthcare expenditure (3.3% vs. 
3.5% of GDP), OKP expenditure rises only half as much by 2045 (+0.8% vs. +1.5% of GDP). 
The latter is attributable to the fact that the proportion of dynamically developing long-term care 
expenditure is much lower for OKP (9%) than it is for the general government (23%) in the 
reference year 2013.  
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Conclusions 
These projections show that demographic change will have a significant impact on the 
dynamism of healthcare expenditure. The effect of an ageing population is most significant in 
the area of long-term care. For healthcare excluding long-term care, non-demographic cost 
drivers – such as the Baumol effect and determinants captured indirectly by income elasticity 
such as advances in medical technology and market failures as a result of asymmetric 
information – are likewise very significant. As the key player in this area, (acting not just as 
regulator, but also as a source of financing and service provider), it is the cantons that will have 
to bear the main burden of rising healthcare expenditure. In addition, the public sector will be 
more heavily affected by an ageing population than OKP, as the general government sector 
spends a greater proportion of its funds on long-term care than OKP.  
 
The projections provide the following pointers for the orientation of healthcare policy. On the 
one hand, measures should be promoted that sustainably alleviate the illness burden on the 
population, particularly in the case of chronic conditions, thereby facilitating healthy ageing. 
The focus here should be on strengthening healthcare skills and promoting healthy lifestyles 
by means of adequate preventive measures. On the other hand, existing efficiency reserves 
need to be better exploited by avoiding unnecessary treatments, incorporating cost-benefit 
considerations more strongly into the design of the OKP service catalogue (health technology 
assessment), and ensuring that the increasing productivity of medical services is appropriately 
reflected in the corresponding prices and tariffs. While the new DRG flat-rate payments per 
case should contribute to reducing misplaced incentives and strengthening competition in the 
inpatient area, the obsolete fee-for-service remuneration system in the outpatient area 
generally contains an oversupply incentive, particularly in the case of technical services. A 
strengthening of Spitex and the improved compatibility of professional life and family-based 
care would also help to reduce the length of the average care home stay. Finally, the next two 
decades will see an increase in demand for healthcare and nursing care staff, which will make 
forward-looking personnel planning and an improvement of working processes more 
necessary than ever. 
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1. Introduction 
Healthcare expenditure in Switzerland has more than doubled over the last half-century or so, 
rising from 4.8% of gross domestic product (GDP) in 1960 to 11.1% of GDP in 2014. Swiss 
society is therefore spending an increasing proportion of its income on healthcare. This is a 
trend that Switzerland has in common with other developed economies (see Figure 1). Looking 
back over the last 25 years, it becomes apparent that the rise in healthcare expenditure in 
Germany and France between 1990 and 2014 echoed that of Switzerland. Switzerland has 
one of the most expensive healthcare systems of any OECD country, with the GDP share in 
question (11.1%) being similar to that of Sweden (11.2%), France (11.1%), Germany (11.0%), 
and the Netherlands (10.9%). Only the US spends a significantly greater proportion of its 
income on healthcare (16.6%).  
 
Figure 1: Healthcare expenditure in an international comparison (in GDP percent) 
 
 
Source: OECD and FSO. 
 
An ageing population exhibits greater demand for healthcare services, as well as a greater 
need for care services. In addition to this ongoing, age-related increase in demand for 
healthcare services, the rise in healthcare expenditure is also likely to be driven by a number 
of aspects that are particular to the healthcare system. Specifically, there can be market 
failures in healthcare markets as a result of risk selection on the part of health insurers, 
expenditure-driving incentives as a result of insurance cover ("moral hazard"), and the 
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asymmetrical distribution of information between patients and doctors.2 In the case of the latter, 
a superior level of information on the part of doctors can lead to a market failure known as 
"supplier-induced demand", resulting in a greater degree of treatment than is medically 
necessary.  
 
A number of different objectives were defined with the introduction of the Health Insurance Act 
(HIA) in 1996. Access to high-quality provision of healthcare was to be guaranteed (provision 
objective), and persons with modest incomes would be financially supported (solidarity 
objective). In addition to these distribution objectives, the increase in healthcare expenditure 
was also to be contained (cost containment objective). In view of the special characteristics of 
the healthcare market and the legally defined distribution objectives, strong regulation on the 
part of the state is required. However, there is also a risk of the actual objectives of regulations 
getting lost under the influence of the various powerful interest groups that exist in the 
healthcare system, with the result that healthcare expenditure can potentially balloon. In such 
a scenario, a market failure is then potentially followed by government failures.3 Given the 
complexity of the healthcare system, with its numerous players and the associated transaction 
costs, it is also difficult to design reforms in a precisely targeted way. For example, the 
complexity of the healthcare system is also evident in the sheer number of decision-makers 
and sources of financing involved, a situation that has historical origins and makes it more 
difficult to manage costs and allocate clear responsibilities. Moreover, it should not be forgotten 
that a rise in the general level of prosperity also leads to a rise in the demands made of the 
healthcare system by the population.  
 
A key challenge for the public finances and mandatory health insurance (OKP) is the ongoing 
process of demographic ageing. According to the demographic scenarios of the FSO (A-00-
2015), the proportion of people over the age of 80 relative to the Swiss population is set to 
double from the current level of 5% to 10% by 2045. Whereas in 2013 there were just under 
three full-time workers for every pensioner (effective old-age dependency ratio), this proportion 
will fall to just 1.7 to 1 by 2045 given the assumptions of the FSO's "Reference scenario".  
 
Healthcare is therefore a task area that will present financial policy-makers with major 
challenges for the foreseeable future. For that reason, the healthcare area is also incorporated 
into the calculations of the sustainability of public finances in Switzerland (FDF 2016). The 
expenditure projections calculated here provide greater detail in this area, and should highlight 
                                               
2 For market failures in healthcare and their macroeconomic significance, see Hsiao and Heller (2007). An overview 
of the various challenges in healthcare systems is provided in Glied and Smith (2013). 
3 For a detailed study of distribution aspects, market failures, and government failures in the healthcare system, 
see Rice (2003). 
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the additional future burden on the public finances and mandatory health insurance (OKP) as 
a result of the expected cost pressures in the healthcare system. This Working Paper also 
aims to illustrate the adjustment levers with which the development in expenditure can be 
managed by healthcare policy-makers.  
 
The projections are characterised by significant uncertainties in respect of migration 
development, the assumption about the economic development, the magnitude of the cost 
effects, and the modelling of non-demographic determinants in the healthcare system. The 
latter is particularly true of advances in medical technology. These projections should therefore 
not be understood as forecasts, but represent an extrapolation of long-term trends and their 
repercussions for healthcare expenditure. The projections neither can nor should be used to 
draw any conclusions in respect of the precise magnitude of healthcare expenditure in 30 
years' time. The objective is rather to provide a rough orientation for expenditure development 
and to highlight how sensitively expenditure development reacts to various cost drivers. For 
that reason, scenarios have been drawn up with differing assumptions regarding the impact of 
the relevant cost drivers. For purposes of these projections, it is assumed that the political 
parameters that apply in the healthcare system will not change compared to the status quo 
("no policy change").  
 
Despite this cost-side view, it should be emphasised that a well-functioning healthcare system 
is of great benefit to society, insofar as it contributes to the preservation and improvement of 
the population's state of health. By improving the general state of health, healthcare can have 
a positive impact on economic growth (Suhrcke et al. 2006). For example, a good general state 
of health is conducive to the formation of human capital and therefore productivity growth. 
Furthermore, a well-functioning healthcare system helps a country to exploit the potential of its 
workforce, such as by reducing illness-related absences, for example. In this sense, rising 
costs in the healthcare system are not a negative development as long as they can be set 
against an increase in social well-being of at least a similar magnitude.  
 
Section 2 sets out the projection methodology. Section 3 discusses the key cost drivers and 
describes the various scenarios. Sections 4 to 6 present the results of the projections for the 
total healthcare area, the public sector and OKP. A comparison of these results with the 
predecessor study and the work of the OECD and the EU in this area is provided in Section 7. 
The paper then ends with conclusions for health policy. 
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2. Projection methodology 
Based on the demographic and economic assumptions (section 2.1), this study adopts a 
cohort-based approach, thereby mirroring the methodology adopted by the EU (AWG 2015) 
and the OECD (Section 2.2).  
2.1. Assumptions regarding demographic and economic development 
In keeping with the Report on the Long-Term Sustainability of Public Finances in Switzerland 
(FDF 2016), the "Reference scenario" of the Federal Statistical Office (A-00-2015) has been 
used to capture population development for the projection period 2015-2045 (see Table Annex, 
Table A1). With this timeframe, the costs of demographic ageing – particularly on the part of 
the baby-boomer generation, which is set to enter retirement in the coming years – can be 
captured. According to the "Reference scenario", the Swiss population will rise from its current 
level of some 8.3 million residents to some 10.2 million residents. The driver of this increase is 
the positive annual net immigration rate. This declines from an initial 80,000 persons to 60,000 
persons by 2030, before then levelling out at around 30,000 persons from 2040 onwards. The 
population nonetheless ages as a result of a persistently low (in relative terms) birth rate, which 
works out at around 1.5, along with a rise in life expectancy. As a result, there is a rise in the 
old-age dependency ratio, i.e. the proportion of the working-age population accounted for by 
those aged over 65, from just under 29% today to 48% by 2045. In order to take account of 
the sensitivity of the expenditure projections in respect of uncertainty regarding future 
development of migration, an alternative population scenario with a higher net immigration 
balance is additionally assumed (A-06-2015).  
 
The expenditure projections also require assumptions to be made regarding future economic 
development (see Table Annex, Table A1). These assumptions are the same as those used 
in the Report on the Long-Term Sustainability of Public Finances in Switzerland (see FDF 
2016, Section 2). For the years 2016 to 2019, the key economic figures contained in the federal 
government's Legislature Financial Plan 2017-19 are used. The growth rate of GDP from 2020 
onwards is expressed as a product of assumed economic productivity advances (1.2% p.a.) 
and the development of the working-age population in full-time equivalents (FTE) indicated by 
the demographic scenarios. No economic fluctuations are taken into account with respect to 
the GDP projections, so a growth trend of GDP is assumed. For the years 2013 to 2019, trend 
GDP is estimated with the assistance of the so-called "k coefficient" (business cycle adjustment 
factor) as per Switzerland's debt brake rule.  
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2.2. Methodology 
As a number of different cost drivers (or in some cases the same cost drivers) exercise their 
influence to a differing extent in different areas of the healthcare system, for purposes of the 
expenditure projections healthcare expenditure is broken down into the areas of healthcare 
excluding long-term care (HeL) and long-term care from the age of 65 (LTC). The residual area 
is therefore that of long-term care for persons aged under 65. On the basis of this breakdown, 
the total expenditure of each area is projected in a first step. In the next step, the proportion of 
healthcare expenditure financed by both the public sector and OKP are extrapolated along 
with the expenditure projected for the total healthcare area.4  
 
The healthcare expenditure is taken from the FSO's "Costs and Services of the Healthcare 
System" statistics. The most recent data available at the time the projections were drawn up 
dates back to 2013, which is why this year forms the base year for the projections. The graphic 
illustration of expenditure per capita of population by age is described as the expenditure profile 
for a given year. For example, in Figure 2 the expenditure profile for outpatient treatment in 
HeL for women is shown for the base year and for the year 2045 under the "Healthy ageing" 
scenario. In order to project expenditure for the HeL and LTC areas, the expenditure profiles 
are further divided up by gender as well as by outpatient and inpatient treatment (see Annex). 
The latter distinction is required for the projections of public healthcare expenditure. If the per 
capita expenditure for the age cohorts of these expenditure profiles for the base year are 
multiplied by the development of the population in the relevant age cohorts as per the FSO's 
projections, the effect on healthcare expenditure of the change in age structure and population 
size can be seen. Expenditure per capita of population can effectively be viewed as the price 
of supplying the population with healthcare services at a given level. This expenditure per 
capita of population can then be broken down into the price of services per patient on the one 
hand, and the scope of service (e.g. treatments, medications) per capita of population on the 
other.5 It is therefore assumed that demographic changes affect neither the cost side nor the 
scope of service per resident side. As a consequence, the cost effect of demographic change 
expresses how a change in the ageing structure of the population and the number of residents 
in Switzerland changes total demand for healthcare services. For simplicity's sake, expenditure 
on long-term care for those aged below 65 is extrapolated on the basis of the change in GDP. 
 
Figure 2: Expenditure profile for outpatient treatment of women in HeL by age in the base 
year and in 2045 under the "Healthy ageing" scenario (CHF) 
                                               
4 For a detailed description of the projection methodology, see Colombier (2012). 
5 The expenditure per capita by age cohort can be broken down into a price effect and volume effect per patient 
treated on the one hand, and the probability of falling ill on the other: Expenditure per service ("price") x utilisation 
per patient x patients per capita of an age cohort, whereby the product of utilisation per patient and patients per 
capita of an age cohort results in the scope of service per capita of an age cohort.  
14 
 
 
 
 
The starting point for the projections is the expenditure profiles broken down by age, gender, 
and outpatient or inpatient services. The FSO then breaks down these profiles further into five-
year age cohorts. According to a number of epidemiological theories, the life expectancy 
assumed in the demographic scenarios has a close correlation with the development of the 
population's state of health and need for care (morbidity rate). In order to capture changes in 
morbidity in the projections adequately, however, healthcare expenditure needs to be 
annualised. In addition, for the analysis of the impact of morbidity, the probability of each age 
group falling ill or requiring care needs to be known. However, information on these illness 
frequencies is only available in incomplete form, which is why the change in expenditure per 
inhabitant is used as an approximation for the change in morbidity. In contrast to this study, 
the EU and the OECD use so-called morbidity rates for the extrapolation of LTC expenditure.  
 
If the state of health of the population improves over the projection period, the expenditure per 
capita of an age cohort falls, and the expenditure profile shifts to the right (see Figure 2). Here 
it is assumed that the probability of falling ill or requiring care declines. At the same time, for 
our model this means that a change in morbidity influences neither the expenditure on a 
medical or care service, nor the degree of utilisation per patient. As the probability of falling ill 
or requiring care falls, however, so too does the scope of service per capita for an age cohort. 
The cost pressure exerted by non-demographic cost drivers such as advances in medical 
technology expresses itself in rising expenditure per capita of an age cohort. As a similar effect 
of non-demographic cost drivers is assumed for all age cohorts, the expenditure profile 
accordingly shifts upwards.6 This increase in expenditure is either caused by rising expenditure 
                                               
6 There are a number of indications to the effect that the expenditure profile steepens with time, and that the age 
cohorts are therefore affected to different degrees by the cost pressure of non-demographic cost drivers such as 
advances in medical technology (e.g. Gregersen 2014). This could imply, for example, that research efforts to 
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per service or by an increasing degree of utilisation per patient, or by a combination of the two, 
and has the effect of increasing the price of providing healthcare services for the population. 
Changes in quality in the provision of services are not taken into account in this approach.7  
 
For the HeL area, the annualisation of the expenditure profiles is only undertaken over the age 
of 40. This is due to the fact that per capita expenditure in the base year 2013 is relatively low 
up until the age of 40, with a comparatively weak rise, whereas morbidity poses a problem in 
old age in particular. For the annualisation, it is assumed that the average expenditure of a 
five-year age cohort corresponds in each case to the expenditure that applies for the median 
age of this age cohort. For the age cohort "96 and over", it is assumed that expenditure per 
capita remains constant.8 Due to major differences in life expectancy at different ages, as well 
as between women and men, morbidity effects are determined not by the change in average 
life expectancy of the overall population, but by the change in life expectancy based on age 
and gender. For example, the profile illustrated in Figure 3a shows the per capita expenditure 
on inpatient hospital care for women and men in the base year 2013. Figures 3b to 3d show 
the expenditure profiles for the services of care homes and outpatient treatment for HeL and 
LTC. 
 
Figure 3a: Expenditure profile for inpatient treatment in hospitals – base year 2013 (CHF)
 
                                               
develop new medications are particularly focused on medications for the older age cohorts, as old people are 
disproportionately affected by serious illnesses such as cancer and cardiovascular disease. 
7 In the case of a price rise as a result of advances in medical technology, the extent to which the level of provision 
rises as a result of quality improvements is not clear. Potential quality improvements would have to be offset against 
the price effect in order to capture the effective price rise. This is an extremely challenging task even for past 
developments in healthcare expenditure, and goes beyond the methodological approach selected here.   
8 The underlying FSO statistics, namely "Costs and Services of Healthcare by Age and Gender", do not go beyond 
the age cohort "96 and over".  
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Figure 3b: Expenditure profile for inpatient treatment in care homes – base year 2013 (CHF)
 
Figure 3c: Expenditure profile for outpatient treatment in the area of healthcare excluding 
long-term care – base year 2013 (CHF)
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Figure 3d: Expenditure profile for outpatient treatment in the area of long-term care from the 
age of 65 – base year 2013 (CHF)
 
 
Healthcare expenditure is typically expressed as a proportion of (trend) GDP. GDP is an 
indicator of national income. Expressing healthcare expenditure as a proportion of GDP shows 
what proportion of a society's income is effectively spent on health. The extent to which an 
increase in healthcare expenditure represents an additional burden for society as a whole and 
for individual sources of financing such as the public sector and OKP can thus also be 
illustrated. Moreover, if healthcare expenditure is expressed as a percentage of GDP, the effect 
of population growth on healthcare expenditure is factored out. This can be illustrated very 
simply: If it is assumed that all age cohorts of the population grow at the same percentage rate, 
the population structure will not change. Accordingly, the working-age population as a 
proportion of the total population will remain constant. Correspondingly, the GDP growth 
resulting from an increase in the working-age population is virtually the same as the increase 
in healthcare expenditure. As a consequence, population size has no impact on the 
relationship between healthcare expenditure and GDP.  
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3. Cost drivers and scenarios 
3.1. Cost drivers in healthcare 
The key determinants of healthcare expenditure in developed economies as debated in 
academic literature are ageing, the state of health of the population (morbidity), proximity to 
death (mortality), income development, advances in medical technology, Baumol's costs 
disease, and the institutional and political parameters of the healthcare system, such as 
insurance cover for the population and compensation systems for service providers. However, 
the extent of the correlation between these different determinants and healthcare expenditure 
is often far from clear.9  
 
Ageing and state of health 
In addition to the immediate repercussions of demographic change for healthcare expenditure, 
the aim is to highlight those effects that can have an expenditure impact as a result of a change 
in the health situation (morbidity) of an ageing population. Here, the question arises as to 
whether the morbidity of the population changes in keeping with increasing life expectancy. A 
number of different competing hypotheses have emerged in this respect. According to the 
thesis of pure morbidity extension, so-called "pure ageing", the additionally gained years of life 
are not spent in good health (Gruenberg 1977). The state of health of the population 
deteriorates. The thesis of a relative reduction in morbidity, so-called "healthy ageing", states 
that the amount of time spent in a state of illness or in need of care does not change. However, 
the extra years of life gained are spent in a good state of health (Manton 1982). The thesis of 
an absolute reduction in morbidity in the event of rising life expectancy is put forward by Fries 
(1980; 1989), who argues that as a result of better technology and better prevention, the 
amount of a person's lifetime spent in sickness or in need of care can actually be compressed. 
The amount of time spent in good health rises more strongly than life expectancy. As there is 
no clear consensus in empirical studies with respect to the interaction of rising life expectancy 
and morbidity development, scenarios with different assumptions regarding the change in 
morbidity have been drawn up. 
  
Income development, medical progress, and Baumol's cost disease 
Aside from the effects of demographic change, the projections also include the effects of 
important non-demographic cost drivers. The first non-demographic factor to be taken into 
consideration is the empirically observable relationship between national income development 
and healthcare expenditure growth. In the past, the latter grew disproportionately to national 
income. This relationship covers both supply-side and demand-side effects, such as advances 
                                               
9 For an overview, see Martín et al. (2011), De la Maisonneuve and Oliveira Martins (2014), and Gerdtham and 
Jönsson (2000). 
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in medical technology and the demand of the population for healthcare services. As advances 
in medical technology are very difficult to quantify from an empirical standpoint, it is assumed 
in these projections that the cost effect of advances in medical technology can be indirectly 
captured through the change in national income development. According to Smith et al. (2009), 
close interdependencies exist between advances in medical technology and national income: 
As a society becomes more prosperous, it may be assumed that its demand for medical 
innovations will rise ("demand pull"). At the same time, as a society becomes increasingly 
prosperous, so too is there an increase in selling opportunities for healthcare services, which 
has the effect of increasing the incentive to invest in research and development ("supply 
push"). Box 1 gives a brief overview of the relationship between income development and 
healthcare expenditure.  
 
Box 1: Overview of income elasticity of healthcare expenditure 
 
A key question is whether the demand for healthcare services (and therefore healthcare expenditure) 
rises disproportionately to income, thereby making healthcare services a so-called "luxury good". At 
an individual level, the extent of income elasticity depends heavily on insurance cover. The greater 
the degree of insurance cover, the less sensitively demand for healthcare services reacts to changes 
in income. Where insurance cover is in place, budget restriction kicks in only at the level of the 
insurance pool. As insurance is mandatory in many developed economies, a strong positive 
relationship tends to be empirically discernible only at the aggregated, macroeconomic level. 
Furthermore, the individual income only captures advances in medical technology in an incomplete 
way – a situation that changes when national income is observed instead.  
 
Early empirical analyses suggest that healthcare expenditure represents a so-called "necessary 
good" at an individual level and a "luxury good" at aggregated level (see Gerdtham and Jönsson 
2000). However, there is no clear consensus on a precise assessment of income elasticity at 
aggregated level. More recent studies are often based on more comprehensive databases and use 
advanced empirical methods in order to address problems such as the distortions that arise when 
important determining factors are neglected or as a result of endogeneity. These studies typically 
suggest an income elasticity of slightly below 1 (cf. Baltagi and Moscone 2010, Hartwig and Sturm 
2014, De la Maisonneuve and Oliveira Martins 2014 for OECD panel analysis, Medeiros and Schwierz 
for the European Union 2013, Moscone and Tosetti 2010 and Acemoglu et al. 2013 for panel analyses 
in the US, as well as Costa-Font et al. 2011 for a meta-regression analysis).  
 
In the case of Switzerland, Colombier (2016) uses a time series analysis for total healthcare 
expenditure to show a systematic, positive partial correlation with national income, whereby the 
corresponding income elasticity is around 1. For a cantonal panel dataset for the period 1970-2012, 
Braendle and Colombier (2016) identify – in keeping with the results of the latest research literature 
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– a robust partial correlation between income and cantonal healthcare expenditure, whereby the 
estimated income elasticity lies just under 1. Vatter and Rueffli (2003), who investigate the 
determinants of healthcare expenditure for a cross-section of cantons and communes for the years 
1994-1999, find a positive partial correlation between canton income and public healthcare 
expenditure. Where OKP expenditure is concerned, the authors find a positive but not significant 
partial correlation. Crivelli et al. (2006) and Reich et al. (2012) investigate the aggregated sum of 
cantonal healthcare expenditure and OKP expenditure at cantonal level. For a significantly shorter 
timeframe, namely 1996 to 2002 or 1997 to 2007 (due to the incorporation of OKP data), these studies 
cannot show any positive correlation between cantonal income and healthcare expenditure. 
 
The second factor concerns productivity development in healthcare. This is difficult to measure 
empirically, and may indeed differ from area to area. For example, productivity advances in 
labour-intensive long-term care may be minimal, whereas in the more capital-intensive and 
technology-intensive hospital sector, productivity gains could reasonably be expected. Lower 
productivity growth relative to the overall economy results in cost pressure if healthcare wages 
keep step with wage growth in the remainder of the economy in the longer term. Given a 
relatively inelastic demand for healthcare services, healthcare prices accordingly rise more 
strongly than in the remaining economy. In the jargon of healthcare economics, this price effect 
is known as the "Baumol" effect (Baumol 1967). Significant importance is attached to this effect 
in the case of long-term care in particular.10  
  
Determinants and trends not taken into consideration 
The thesis that it is not ageing itself that drives up healthcare costs but proximity to death is 
the subject of considerable attention in academic literature on healthcare economics ("red 
herring" thesis).11 It has been pointed out that expenditure per capita is significantly higher for 
persons who are close to death (mortality cases) than for persons who live longer (survivors). 
According to the "red herring" thesis, expenditure projections that do not make a distinction 
between mortality cases and survivors overestimate the ageing effect.12 However, both the 
temporal and the macroeconomic dimension are neglected in the corresponding empirical 
analyses, which leads to different conclusions. Breyer et al. (2015) show that "red herring" 
literature neglects the impact of continuously rising life expectancy on healthcare expenditure. 
For example, with rising life expectancy, interventions such as hip operations become 
worthwhile even at a later stage in life. Breyer et al. (2015) have been able to show the rise in 
                                               
10 Empirical estimates from Switzerland suggest that this effect is only partially applicable in healthcare (see 
Colombier 2016). Panel analyses for the OECD countries (Hartwig and Sturm 2014; Colombier 2017, Hartwig 2008) 
and for US federal states (Bates and Santerre 2013) emphasise the significance of the Baumol effect for healthcare 
expenditure growth. 
11 A "red herring" is something that misleads or distracts from the real issue. Healthcare policy is therefore 
essentially wasting its time by scrutinizing the ageing effect. See for example Zweifel et al. (1999).  
12 See Stearns and Norton (2004), Polder et al. (2006) or Breyer and Felder (2006). 
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expenditure as a result of ageing through this effect – which they describe as the "Eubie-Blake" 
effect – for a statutory health insurance dataset in Germany. Colombier and Weber (2011) 
have also shown (for Swiss data) that the expenditure per mortality case at a high age (above 
90 or so) works out below the expenditure per survivor. Accordingly, it is not clear on an a priori 
basis whether mortality case costs have a restraining effect or a reinforcing effect on total 
expenditure. According to the demographic scenarios of the FSO, the number of the very 
elderly increases in line with rising life expectancy. Correspondingly, the ageing effect in an 
earlier edition of the expenditure projections taking into account mortality cases and survivors 
was barely any weaker than if this distinction was not made (see Colombier and Weber 2011). 
Van Baal and Wong (2012) come to a similar conclusion for the Netherlands, showing that the 
projections do not react very sensitively to the inclusion of mortality costs.13 In view of the 
additional data and modelling work involved, therefore, mortality costs have not been taken 
into consideration in our projections. 
 
Furthermore, institutional and political parameters also play a role in the development of 
healthcare expenditure. Many institutional differences have been looked at by comparative 
literature on healthcare economics. Prominent examples here include the repercussions of 
different insurance and financing regimes, different compensation systems for service 
providers, and the role of general practitioner models. Clear (empirical) conclusions regarding 
their cost impact are often not possible, however. No such scenarios have been drawn up for 
the projections of this study, which takes the existing parameters of the Swiss healthcare 
system for its basis.  
 
Also not taken into consideration here are trends such as the continuous move away from the 
tradition of family-based care for the elderly as a result of the increasing female labour 
participation rate, which goes hand in hand with an increasing burden on institutional care 
(care homes and Spitex), or medical innovations that have the effect of shifting healthcare 
treatment from an inpatient to an outpatient basis, such as micro-invasive operations. The 
degree of uncertainty over the extent and duration of these trends is very high. For example, 
in the FSO "Reference scenario" (A-00-2015) it is assumed that the female labour participation 
rate (measured in FTEs) is set to rise by a very small amount between 2015 and 2045, namely 
from the existing level of just over 40% to 42% (see FSO 2015a, Table TA 13). This does not 
allow any clear prediction to be made about a future persistent trend of a shift in care for the 
elderly away from family care to institutional care. 
 
                                               
13 A recent discussion of this can be found in Felder (2013). 
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3.2. Scenarios  
For the above-mentioned cost drivers, the following assumptions are made for the projections 
of healthcare expenditure excluding long-term care:  
 
 "Reference scenario": With respect to the change in the population's state of health, it 
is assumed for the healthcare area that the extra years of life gained are spent half in 
a good state of health and half in a poor state of health. In addition, the increase in 
national income has a disproportionately high impact on the increase in healthcare 
expenditure through demand and supply-side effects. An income elasticity of 1.1 is 
assumed. The Baumol effect is not factored into considerations. Population growth is 
extrapolated in accordance with scenario A-00-2015 of the Federal Statistical Office. 
 In the "Pure ageing" scenario, by contrast, it is assumed that the population spends the 
additional years of life gained in a poor state of health (extension of morbidity).  
 In the "Healthy ageing" scenario, the population spends the extra years of life gained 
in good health (relative decrease in morbidity).  
 "Migration" scenario: In contrast to the "Reference scenario", the "Migration" scenario 
is based on demographic scenario A-06-2015, which assumes a higher net immigration 
rate. Due to the sharper increase in the working-age population, economic growth is 
stronger than in the reference scenario.  
 "Baumol" scenario: Unlike in the reference scenario, it is assumed that the Baumol 
effect manifests itself. It is therefore assumed in the Baumol scenario that productivity 
advances in healthcare (excluding the long-term care area) are some 40% lower than 
in the economy as a whole. 
 "Expanded Baumol" scenario: In the area of healthcare excluding long-term care, a 
Baumol effect of 60% is assumed. The productivity advance in the area of HeL lags 
behind overall economic productivity advance by 60%.14 The long-term care area 
experiences a low advance in productivity (25% of the overall economic average). Only 
75% of the Baumol effect manifests itself in the long-term care area. This figure is 
based on the level of staff costs as a proportion of overall costs in the care home area 
(see Credit Suisse 2015, p. 27).  
 "Cost pressure" scenario: In this scenario, is it assumed that non-demographic cost 
determinants – such as advances in medical technology, an increase in doctor 
densities as a result of the incentives that exist in the healthcare system, and the 
increasing degree to which the population draws on healthcare services – trigger 
significantly stronger expenditure growth than in the reference scenario. This in turn 
                                               
14 According to an empirical analysis for Switzerland, this is the highest possible estimated value for the Baumol 
effect that is still compatible with the sample (see Colombier 2016). 
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translates into expenditure rising more strongly in the event of rising income. Based on 
the corresponding European Commission scenario, income inelasticity of 1.4 is 
assumed (see AWG, 2015, p. 126). 
 
The same assumptions regarding demographics and morbidity (i.e. the need for care) used for 
the area of healthcare excluding long-term care are also applied to the scenarios for long-term 
care itself. However, other than in the "Expanded Baumol" scenario, it is assumed in the 
scenarios for long-term care that no productivity advances are achievable, and that the Baumol 
effect is therefore fully effective. In addition, no income effect comes into play in the long-term 
care area, as the need for care is not voluntary and is independent of income. Accordingly, no 
"Cost pressure" scenario is drawn up for the long-term care area.  
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4. Total healthcare expenditure 
The projections for healthcare expenditure reveal that the development pattern of the past will 
continue. According to the "Reference scenario", expenditure will rise from 10.8% of GDP in 
2013 to 14.0% of GDP in 2045 (see Figure 4). For the years 1995 to 2013, health expenditure 
rose from 8.7% of GDP to 10.8% of GDP (whereby GDP is cyclically adjusted). A distinction 
can be made between two different phases over this timeframe: Between 1995 and 2004, the 
healthcare sector underwent a significant expansion. Expenditure on healthcare rose by 1.7% 
of GDP. Thereafter the proportion of GDP accounted for by healthcare expenditure actually 
declines, and not until 2012 does it rise back above the level it reached back in 2004. This 
development is attributable primarily to the fact that nominal economic growth between 2005 
and 2013 (+3.0%) proved significantly higher than the average for the period 1995 to 2004 
(+2.2%). At the same time, the average annual increase in healthcare expenditure slowed 
slightly from 4.0% to 3.5%. The latter development is attributable to the fact that the momentum 
of expenditure growth for outpatient and inpatient healthcare services (excluding the long-term 
care area) slowed significantly, namely from 4.1% to 3.4%. By contrast, annual growth in 
expenditure on long-term care remained more or less unchanged at around 4.7%. Accordingly, 
the proportion of expenditure on long-term care as a total of healthcare expenditure increased 
from 13% to 15% between 2005 and 2013, whereas it rose just one percentage point between 
1995 and 2004. 
 
Figure 4: Healthcare expenditure by area from 1995 to 2013 and in the reference scenario (in 
% of GDP) 
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According to the reference scenario, the trend towards significantly higher expenditure growth 
for long-term care (from 65 years of age) than for healthcare excluding long-term care will 
continue in the future. Measured as a percentage of GDP, expenditure on long-term care (from 
the age of 65) more than doubles (rising from 1.6% to 3.4% of GDP), while healthcare 
expenditure rises from 8.6% to 9.9%. On the one hand, demographic change (ageing, including 
the associated change in the average state of health) feeds through into the long-term care 
area to a much greater extent (72% of the rise in expenditure) than it does in the remaining 
healthcare area (just under 60% of the rise in expenditure). On the other hand, expenditure on 
long-term care rises by 2.2% annually as a result of the Baumol effect, whereas expenditure 
on healthcare as a result of rising income per capita rises by just under 1.9% annually.  
 
Figure 5: Scenarios for total healthcare expenditure 2013-2045 (in GDP %) 
 
 
In order to reflect the uncertainty that exists over the future development of healthcare 
expenditure, various different scenarios are applied (see Figure 5). In the most optimistic 
scenario, healthy ageing, healthcare expenditure increases by only 13.1% of GDP rather than 
14.0% of GDP (as in the "Reference scenario"), thanks to the improved state of the population's 
health by 2045. In the most pessimistic scenario, the "Expanded Baumol" scenario, healthcare 
expenditure rises by 15.7% of GDP by 2045. The pronounced Baumol effect in the larger area, 
HeL, is a significant contributor to this increase. 
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Figure 6: Breakdown of expenditure by financing source in 2008, 2013 and 2045 in the 
reference scenario (in %)
 
Notes: The source Other includes private households, the accident insurance (SUVA) and military insurance, 
foundations and supplementary insurances. 
 
The breakdown in healthcare expenditure by source of financing in Figure 6 shows that the 
proportion of expenditure met by OKP and the government increased from 60% to 63% 
between 2008 and 2013.15 This is attributable in particular to the healthcare policy reforms, 
namely the new care financing model and the new hospital financing model ("Swiss DRG"), 
which were introduced in 2011 and 2012 respectively. According to the projections, 
government healthcare expenditure also rises by a very disproportionate amount by 2045 
when compared to OKP expenditure. This is explained primarily by the fact that the proportion 
of expenditure accounted for by long-term care (from the age of 65) is significantly higher for 
the general government sector in the base year 2013 (23%) than it is in the case of OKP (9%) 
and healthcare overall (15%). 
4.1. Healthcare excluding long-term care 
The HeL area encompasses expenditure on inpatient treatment in hospitals (including 
psychiatric clinics), outpatient treatment (in medical practices and hospitals, physiotherapy, 
psychotherapy), medicines, therapeutic devices, dental treatment, administration, prevention, 
and other services such as laboratory services, transport and rescue. Expenditure on 
administration, prevention, and other services, which accounted for some 18% of expenditure 
                                               
15 For a detailed overview of expenditure development in the "Reference scenario" by healthcare area and financing 
source, see Table Annex, Table A2. 
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on HeL in the base year 2013, is extrapolated on the basis of GDP, as these areas are not 
exposed to the same cost drivers as the other areas of healthcare. For simplicity's sake, the 
same approach is used for expenditure on dental treatment – which is negligible for the 
expenditure of the public sector and OKP – and expenditure on institutions for the disabled 
and other institutions.16  
 
According to the "Reference scenario", expenditure on HeL rises from 8.6% of GDP in 2013 to 
9.9% of GDP in 2045 (see Figure 7). Expenditure on inpatient treatment in hospitals and 
outpatient treatment rises by different degrees on the basis of different expenditure profiles in 
the base year (see Figures 3a and 3c). Expenditure on outpatient treatment increases in the 
observed period from 4.3% to 4.9% of GDP. Expenditure on hospitals rises from 3.0% of GDP 
in 2013 to 3.7% of GDP in 2045. It should be noted that the dynamism of expenditure for 
hospitals is on average rather higher (nominal 3.0% rise annually) than it is for outpatient 
treatment (2.8%). Accordingly, the relative significance of hospital expenditure rises slightly 
against a backdrop of an ageing population. The relative weighting of other healthcare 
expenditure, such as for administration and prevention, declines slightly. The share of 
expenditure accounted for by outpatient treatment remains constant.  
 
Figure 7: Scenarios for healthcare expenditure excluding long-term care 2013-2045 (in GDP 
%) 
 
                                               
16 Dental treatment accounts for a very low proportion of public expenditure at the moment, namely 1%, while for 
OKP it is even lower at 0.3%. 
In addition to the institutions for the disabled, the heading "institutions for disabled and other institutions" includes 
establishments for addicts and people with psychosocial problems. This heading therefore also includes 
expenditure on long-term care for those below the age of 65, as well as on short-term care and medical services, 
which makes clear assignment difficult. For simplicity's sake, this heading has been assigned to "other expenditure" 
in the HeL area. In 2013 this expenditure amounted to just under 0.6% of GDP. 
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The range between the most optimistic scenario (healthy ageing) and the most pessimistic 
"Expanded Baumol" scenario amounts to 2.4% of GDP in 2045 (see Figure 7). A striking 
feature is that changes in assumptions in respect of the Baumol effect and income elasticity 
have a greater impact on expenditure development in the HeL area than a change in morbidity 
assumptions with increasing life expectancy. In the "Pure ageing" scenario, expenditure 
increases more strongly up to 2045 (10.4% of GDP) than in the "Reference scenario" (9.9% of 
GDP). For the "Cost pressure" scenario, the "Baumol" scenario and the "Expanded Baumol" 
scenario, the differences vis-à-vis the "Reference scenario" are significantly greater at +0.7%, 
+1.3%, and +2% of GDP respectively. These scenarios show that, compared to the "Reference 
scenario", greater cost pressure can arise over the long term as a result of non-demographic 
determinants such as the Baumol effect and advances in medical technology. The rise in 
expenditure in the "Cost pressure" scenario is weaker than in the Baumol scenarios, since per 
capita income (on an inflation-adjusted basis) rises less strongly each year on average (0.9%) 
than productivity and therefore wages (1.2%). While the development of labour productivity 
and wages is key to the Baumol effect, the impact of the other non-demographic cost drivers 
such as advances in medical technology is captured in these projections via per capita income. 
A healthy ageing of the population as per the eponymous scenario would slow the rise in 
expenditure in the HeL area by just under 0.4% of GDP by 2045. By contrast, higher net 
immigration, as assumed in the "Migration" scenario, has virtually no impact. It is assumed that 
the net immigration figure primarily relates to persons of a working age. As a consequence, 
the ageing structure of the population changes, giving rise to two effects on HeL expenditure 
that virtually cancel each other out (in GDP terms): On the one hand, demand for healthcare 
services rises due to the larger population, while on the other hand aggregated GDP rises 
more strongly than in the "Reference scenario", as the people coming to Switzerland are 
primarily of a working age.  
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Figure 8: Contributions to the inflation-adjusted rise in healthcare expenditure 2013-2045 (in 
%)
 
 
Irrespective of the hypothesised scenario, ageing contributes to the rise in inflation-adjusted 
expenditure most strongly in the HeL area (see Figure 8). The higher the cost pressure of the 
non-demographic cost drivers (income and Baumol effect), the lower the relative ageing effect. 
As is clear from the breakdown of gross contributions of the two Baumol scenarios, the income 
effect remains the strongest non-demographic cost driver. This is attributable to the fact that 
the HeL area is assumed to be not wholly affected by Baumol's cost disease.  
4.2. Long-term care from the age of 65 
The long-term care area comprises expenditure on inpatient services in care homes as well as 
care services delivered on an outpatient basis (Spitex). It should be noted that the definition of 
long-term care applied here is restricted to expenditure in respect of persons who are 65 or 
older. In the base year 2013, the total expenditure on long-term care (from the age of 65) 
amounts to 1.6% of GDP. Of this amount, approximately 85% relates to care homes and the 
remainder to the Spitex area.  
 
Long-term care is more affected by the ageing of society than other areas of healthcare. The 
ageing of the generation born in the baby-boomer years (from the end of the 1940s to the mid-
1960s) and a further increase in life expectancy will lead to a strong rise in the age cohorts 
above the age of 80 over the next few decades. The cost-driving impact of demographic 
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change is strengthened by the development of wage costs, as in the scenarios for long-term 
care it is assumed that no (or only minor) productivity advances are achievable in this labour-
intensive area. With a full Baumol effect, i.e. with no productivity advances, the cost growth in 
the LTC area sees the wages of healthcare employees increase in step with wages in the 
remainder of the economy. A combination of this full Baumol effect and demographic change 
leads to an average nominal growth rate of 4.8% annually in the "Reference scenario" over the 
entire projection period – a much greater degree of expenditure dynamism than is apparent in 
the case of expenditure on HeL (2.8%). Accordingly, total expenditure on long-term care rises 
to 3.4% of GDP by 2045 in the "Reference scenario".  
 
The change in the need for care (morbidity rate) is one of the greatest levers for influencing 
expenditure development in long-term care (see Figure 9). While expenditure on long-term 
care rises strongly in the "Pure ageing" scenario to 3.9% of GDP by 2045, expenditure in the 
"Healthy ageing" scenario rises to just 3% of GDP. With greater net immigration ("Migration" 
scenario), the rise in expenditure compared to the "Reference scenario" can hardly be 
restrained. As net immigration primarily involves persons of a working age, GDP rises, which 
in turn leads to a slight reduction in expenditure on long-term care as a proportion of GDP. In 
the "Expanded Baumol" scenario, only a partial Baumol effect in long-term care is 
hypothesised. Unlike in the "Reference scenario", a certain advance in productivity in the long-
term care area is assumed. In this scenario, expenditure on long-term care is projected to rise 
to 3.1% of GDP by 2045. 
 
Figure 9: Scenarios for long-term care expenditure (from the age of 65) 2013-2045 (in GDP 
%)
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When looking systematically at the contributions of the individual cost drivers, it emerges 
clearly that ageing and morbidity have a stronger impact in the long-term care area than they 
do in the area of healthcare excluding long-term care (see Figure 10). As in the "Healthy 
ageing" scenario, the process of ageing can explain up to 94% of the inflation-adjusted rise in 
expenditure by 2045. Apart from in the "Pure ageing" scenario, however, the cost-driving 
ageing effect is partly offset in all scenarios by a reduction in the need for care. In the "Healthy 
ageing" scenario, 68% of the contribution to the rise is explained by demographic cost drivers 
(ageing plus morbidity). Depending on the scenario, between just under 23% ("Expanded 
Baumol" scenario) and 32% ("Healthy ageing" scenario) of the price-adjusted rise in 
expenditure between 2009 and 2045 can be explained by the Baumol effect.  
 
Figure 10: Contributions to the inflation-adjusted rise in expenditure in long-term care (from 
the age of 65) 2013-2045 (in %)
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5. Public healthcare expenditure 
Public expenditure on healthcare comprises all contributions of the federal government, 
cantons and communes, as well as the social security funds for financing healthcare. For each 
of the three levels of government, the expenditure figure in question is that contained under 
the "Health" section of the national financial statistics (FFA, 2015). Also included are 
government transfers to private households designed to finance healthcare benefits, such as 
individual premium reductions and cantonal AHV supplementary benefits. Where the social 
security funds are concerned, the relevant areas are those which belong to the government 
sector and receive payments from the government sector as per the national accounts. The 
scope is therefore essentially restricted to AHV and IV.17 Just like overall expenditure, public 
healthcare expenditure is broken down into the areas of healthcare excluding long-term care, 
and long-term care from the age of 65. Other public sector contributions to healthcare, such 
as preventive measures and administration, are extrapolated in line with GDP. 
 
Figure 11: Breakdown in public healthcare expenditure by function in the reference scenario, 
2013 and 2045 (in %)
 
As is clear from Figure 11, the public sector devotes the greatest proportion of its healthcare 
expenditure to hospitals (40%), followed by individual premium reduction (IPR) (19%), AHV 
supplementary benefits for care (EL-AHV care) (9%), care homes (7%), and Spitex (4%). The 
                                               
17 In contrast to the terminology used in the Federal Health Insurance Act (HIA, Art. 1), OKP does not form part of 
social insurance in the national accounts. OKP is therefore not included under the social insurance heading in this 
report.  
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remaining contributions come from the social security funds and encompass the AHV 
allowance for the helpless (2%) and IV expenditure (IV allowance for the helpless, IV 
contributions, AHV contributions) on healthcare (9%). A striking point to note according to the 
"Reference scenario" is that in 2045 the public sector will have to spend a far greater proportion 
of its budget on long-term care from the age of 65. On an inflation-adjusted basis, national 
expenditure on long-term care from the age of 65 rises by an annual average of 4%, more 
strongly than expenditure in the HeL area (2.1%). Instead of the current level of 23%, the share 
of expenditure accounted for by care is projected to rise to 34% in 2045. Accordingly, the 
proportion of expenditure accounted for by healthcare excluding long-term care is lower in 
2045, having declined from 68% to 61%. IV expenditure on healthcare falls from 9% to 5%. 
  
According to the reference scenario, general government expenditure rises over the projection 
timeframe continuously, namely from 3.5% of GDP to 4.2% of GDP in 2030, and up to 5.0% 
of GDP by 2045 (see Table 1). The lion's share of general government expenditure here is 
borne by the cantons, namely 68%. For example, a good two thirds of the increase in public 
healthcare spending up to 2045, or 1.1% of GDP, is shouldered by the cantons. Where the 
cantons are concerned, the proportions accounted for by hospitals (2013 share: 58%), AHV 
supplementary benefits (14%), individual premium reductions (12%) and care homes (5%) are 
of significance.  
 
Table 1: Public healthcare expenditure by government level in the reference scenario for 
2013, 2030, 2045 (in % of GDP) 
 
 
The remainder of healthcare expenditure is currently borne more or less equally by the 
Confederation, the communes and the social security funds. Following the cantons, the 
greatest increase in expenditure is exhibited by the communes, whose share in this area 
almost doubles by 2045 (rising from 0.3% to 0.5% of GDP). The strong increase in expenditure 
2013
Quote Quote Differenz
2013-30
Quote Differenz
2013-45
Gesamte Gesundheit 10.8 12.2 +1.4 14.0 +3.2
  Staat (inkl. Sozialwerke)* 3.5 4.2 +0.7 5.0 +1.5
    Bund 0.4 0.5 +0.1 0.5 +0.1
    Kantone 2.4 2.9 +0.5 3.5 +1.1
    Gemeinden 0.3 0.4 +0.1 0.5 +0.2
    Sozialversicherungen* 0.4 0.3 -0.0 0.4 +0.0
      AHV-HE 0.1 0.1 +0.0 0.2 +0.1
      IV-HE/ IV/AHV-Beiträge 0.3 0.2 -0.1 0.2 -0.1
* Zu den Sozialversicherungen zählen die AHV-Beiträge und die AHV-HE, die IV-Beiträge sowie die IV-HE.
2030 2045
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at commune level can be explained by the fact that more than half of healthcare expenditure 
is allocated to long-term care from the age of 65. At federal level, the increase as a proportion 
of GDP is equivalent to around a quarter, which is attributable to individual premium reductions. 
The expenditure of the social security funds remains stable as a proportion of GDP, as the 
increase in the AHV allowance for the helpless is offset by the reduction in IV expenditure 
(long-term care below the age of 65). 
 
Figure 12: Public healthcare expenditure in various scenarios (in % of GDP)
 
 
It can be seen in Figure 12 that the rise in public healthcare expenditure works out differently 
depending on the scenario applied. The span between the most optimistic "Healthy ageing" 
scenario and the most pessimistic "Pure ageing" scenario amounts to a good 0.7% of GDP in 
2045. This is the equivalent of 15% of all expenditure of the public sector in the reference year 
2045, or an inflation-adjusted CHF 7.7 billion.  
 
The strongest impact on the development of public healthcare expenditure can be seen with a 
change in hypotheses concerning i) the correlation between the increase in the population's 
life expectancy and its state of health, and ii) the assumption of a Baumol effect in the HeL 
area. If it is assumed that while the population may be older in the future, it will be neither 
healthier nor less in need of care than the present population ("Pure ageing" scenario), 
expenditure as a percentage of GDP rises by almost a third compared to the "Reference 
scenario" in 2045 (+0.4% of GDP). By contrast, if the population lives out its additional years 
of life in good health and does not require care during these years ("Healthy ageing" scenario), 
the increase in expenditure is around a third lower than in the "Reference scenario" (-0.4% of 
3.0%
3.5%
4.0%
4.5%
5.0%
5.5%
Referenz
Pure Ageing
Healthy Ageing
Migration
Baumol
Baumol,
erweitert
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GDP). Government expenditure rises slightly more than in the "Pure ageing" scenario if a 
substantial Baumol effect of 60% is assumed for HeL, together with lower productivity 
advances in the area of long-term care from the age of 65 (25% of average advance in 
productivity ("Expanded Baumol" scenario). The rise in expenditure works out almost as strong 
if a slightly weaker Baumol effect in the HeL area is assumed, namely 40%, together with a 
complete Baumol effect in long-term care ("Baumol" scenario). A rise in expenditure compared 
to the "Reference scenario" is likewise evident (+0.2% of GDP) if stronger cost pressure on 
the part of non-demographic determinants is assumed ("Cost pressure" scenario), such as 
advances in medical technology.18 A higher net immigration rate than in the reference scenario 
("Migration" scenario) has a slightly cost-restraining effect.  
 
Overall, demographic change is more significant for public healthcare expenditure than it is for 
total healthcare expenditure. The reason for this is that the proportion of public expenditure 
accounted for by long-term care from the age of 65 is 23%, much higher than in the overall 
healthcare area (just under 15%). Accordingly, a change in the state of health against a 
backdrop of increasing life expectancy has significant repercussions for general government 
expenditure. A change in non-demographic cost drivers (Baumol effect, income effect) has a 
particularly strong impact on general government expenditure in the hospitals area. At around 
40%, the share of public sector expenditure accounted for by hospitals is currently relatively 
high when compared to the equivalent percentage of hospital expenditure for healthcare as a 
whole (just under 28%).  
5.1. Public expenditure on healthcare excluding long-term care 
Public healthcare expenditure excluding long-term care has been captured by taking the 
expenditure items listed in the "Health" section of the public financial statistics with the 
exception of the items "Convalescent and nursing home services" and "Outpatient care" 
(Spitex) (FFA, 2015). In addition, individual premium reduction (IPR) expenditure, which is 
included under the function "Social welfare" in the financial statistics, has also been taken into 
account. The inclusion of IPR is justified on the basis that this expenditure is heavily influenced 
by healthcare expenditure, particularly by the area of healthcare excluding long-term care. For 
the sake of simplicity, IPR expenditure has been subsumed into national healthcare 
expenditure. Under this approach, the healthcare expenditure of the public sector now 
comprises three items: hospitals, IPR expenditure and other healthcare expenditure including 
preventive healthcare. 
 
                                               
18 It should be emphasised that the additional increase in expenditure in the "Baumol" and "Cost pressure" scenarios 
relative to the "Reference scenario" is exclusively incurred in the area of healthcare excluding long-term care. In 
the area of long-term care from the age of 65, the assumptions remain the same as in the "Reference scenario". 
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Public expenditure on hospitals is linked to the development of overall hospital expenditure, 
while other healthcare expenditure is linked to the development of nominal GDP. The 
development of IPR expenditure is dependent on the development of mandatory health 
insurance expenditure. For the sake of simplicity, it is assumed that the cantonal share of IPR 
expenditure, which currently lies at around 46%, amounts to 50% over the long term. In other 
words, the Confederation and cantons are each assumed to be financing half of IPR 
expenditure. This assumption has been made because the cantons have a greater degree of 
discretion when it comes to setting conditions for the granting of IPR benefits, which makes it 
difficult to arrive at a reliable forecast regarding the development of the cantonal share. 
 
Table 2: Public healthcare expenditure excluding long-term care by government level and 
function in the "Reference scenario" (in GDP %) 
 
 
Public expenditure on HeL rises in the "Reference scenario" from 2.4% to 3.0% of GDP by 
2045 (see Table 2). A good 60% of this rise in expenditure is attributable to the ageing of the 
population. The remainder of the increase can be explained by non-demographic cost drivers 
such as advances in medical technology and the rise in demand for medical services by the 
population in keeping with rising incomes. One factor holding back the rise in expenditure in 
the "Reference scenario" is the assumed partial improvement in people's state of health as life 
expectancy increases.  
 
As expected, the rise is highest for cantonal expenditure in this area, namely +0.5% of GDP. 
While two thirds of this increase are attributable to hospital expenditure, a good third is due to 
the rise in IPR. By contrast, the increase in the expenditure of the Confederation and the 
communes, something already touched on in the previous section, is relatively small. The 
expenditure of the communes rises slightly as a result of an increase in hospital expenditure. 
When general government expenditure is broken down by function, it emerges that hospital 
2013
Quote Quote Differenz
2013-30
Quote Differenz
2013-45
Gesundheit (ohne Langzeitpflege) 8.6                     9.3                     +0.7 9.9                     +1.3
  Staat 2.4                     2.7 +0.4 3.0 +0.6
    Bund 0.4 0.5 +0.1 0.5 +0.1
    Kantone 1.9 2.1 +0.3 2.3 +0.5
    Gemeinden 0.1 0.1 +0.0 0.1 +0.0
Funktionen
Spital 1.4 1.6 +0.2 1.7 +0.3
IPV 0.7 0.9 +0.2 1.0 +0.3
2030 2045
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expenditure and IPR expenditure rise by a similar amount by 2045, namely 0.3% of GDP in 
each case. 
 
Figure 13: Public healthcare expenditure excluding long-term care according to various 
scenarios (in GDP %) 
 
 
The uncertainty surrounding the expenditure projections manifests itself in the results of the 
different scenarios (see Figure 13). A change in non-demographic cost drivers has a much 
stronger impact on public expenditure on HeL than a change in the population's state of health 
against a backdrop of rising life expectancy. In the most pessimistic scenario, the "Expanded 
Baumol" scenario, which assumes a partial Baumol effect of 60%, the rise in public expenditure 
by 2045 (just under 1.2% of GDP) works out twice as high as the rise in expenditure in the 
"Reference scenario" (+0.6% of GDP). If the Baumol effect were to be somewhat weaker (40% 
effect), the rise would still be 0.4% of GDP higher than in the "Reference scenario". In the event 
of increased cost pressure – such as advances in medical technology or rising needs on the 
part of the population – in the "Cost pressure" scenario, as well as in a situation where the 
general state of health does not improve against a backdrop of rising life expectancy ("Pure 
ageing" scenario), the increase in the rise in expenditure compared to that of the "Reference 
scenario" works out higher at just under 0.2% and just over 0.1% of GDP respectively. By 
contrast, a good state of health on the part of population has the effect of holding back 
expenditure increases. In the "Migration" scenario, as with expenditure on HeL overall (see 
Section 4.1), the effects of an increasing working-age population drives up public expenditure 
on HeL, but this is offset by an increase in GDP. 
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5.2. Public expenditure on long-term care from the age of 65 (LTC) 
According to the financial statistics, public expenditure in the area of long-term care from the 
age of 65 comprises the proportion of expenditure of the cantons and communes allocated to 
convalescent and nursing home services, as well as outpatient care (Spitex), where this care 
is provided to people over the age of 65 (FFA, 2015). Here it is assumed that the proportion of 
public expenditure spent on those aged 65 or older corresponds to the relevant proportion of 
overall care expenditure. According to our estimates, just under 90% of all expenditure on long-
term care is accounted for by long-term care for those aged 65 or older. In addition, public 
expenditure on long-term care includes the cantons' AHV supplementary benefits, which are 
subsumed under the "Social security" function in the financial statistics, and AHV allowances 
for the helpless. 
 
From Table 3 it is apparent that government expenditure as a proportion of GDP increases by 
a half by 2030 (i.e. from 0.8% to 1.2% of GDP) and more than doubles by 2045 (to 1.7% of 
GDP). Corresponding to healthcare, the cantons currently bear the greatest share of public 
expenditure in long-term care from the age of 65, namely 70%. Accordingly, some two thirds 
of the increase in public expenditure on the long-term care area, or 0.6% of GDP, is felt at a 
cantonal level. Where the rise of cantonal expenditure is concerned, almost two thirds is 
attributable to the increase in AHV supplementary benefits. The remaining third is explained 
by an increase in cantonal expenditure on care homes and (to a lesser extent) by an increase 
in Spitex. The expenditure of the communes actually doubles as a percentage of GDP, from 
0.2% to 0.4%. Three quarters of this dynamism relates to the development of expenditure on 
care homes and the remaining quarter to expenditure on Spitex. From a low starting level of 
0.1% of GDP, AHV helpless allowance expenditure doubles by 2045. The lower section of 
Table 3 also shows the development of public long-term care expenditure broken down by 
function.  
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Table 3: Expenditure on long-term care from the age of 65 by government level and function 
in the "Reference scenario" (in GDP %)
 
* For purposes of simplification the AHV-HE function is left out, as this expenditure heading already appears in 
the breakdown by government level. 
 
The uncertainty of the projections is expressed in the fact that the increase in public 
expenditure on long-term care in the most pessimistic "Pure ageing" scenario up to 2045 is as 
much as 0.2% of GDP higher than in the "Reference scenario", while in the most optimistic 
"Healthy ageing" scenario it is 0.2% of GDP lower. In contrast to the "Reference scenario", the 
"Expanded Baumol" scenario assumes only a partial Baumol effect in the long-term care area, 
which is why public expenditure on long-term care works out 0.1% of GDP lower here than in 
the "Reference scenario". 
  
Figure 14: Public healthcare expenditure in respect of long-term care according to various 
scenarios (in GDP %) 
 
2013
Quote Quote Differenz
2013-30
Quote Differenz
2013-45
Langzeitpflege ab 65 Jahren 1.6                     2.3                     +0.7 3.4 +1.8
  Staat 0.8 1.2 +0.4 1.7 +0.9
    Kantone 0.5 0.8 +0.2 1.1 +0.6
    Gemeinden 0.2 0.3 +0.1 0.4 +0.2
    AHV-HE 0.1 0.1 +0.0 0.2 +0.1
Funktion*
Pflegeheime 0.3 0.4 +0.1 0.6 +0.3
Spitex 0.1 0.2 +0.1 0.3 +0.1
EL AHV 0.3 0.5 +0.2 0.7 +0.4
2030 2045
0.5%
1.0%
1.5%
2.0%
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Healthy Ageing
Migration
Baumol,
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6. Mandatory health insurance (OKP) expenditure 
For the purposes of the projections, mandatory health insurance (OKP) expenditure in the 
areas of healthcare excluding long-term care and long-term care from the age of 65 is broken 
down into outpatient and inpatient services. For the base year, the breakdown of expenditure 
has been taken from the statistics of the Federal Statistical Office entitled "Healthcare costs 
and financing by service and financing regime 2013" (FSO 2015b). In order to avoid the 
problem of duplicating general government expenditure, OKP expenditure in this study is 
presented after the deduction of individual premium reduction (IPR) expenditure. In addition, 
the cost contributions of private households (deductible, co-payments) has been deducted. 
OKP expenditure is extrapolated using projected expenditure development for healthcare 
excluding long-term care and long-term care from the age of 65. Accordingly, the differing 
expenditure developments in healthcare excluding long-term care and in long-term care from 
the age of 65 feed through into the OKP projections. 
 
Although the starting level is at roughly the same level as for public healthcare expenditure 
(3.3% vs. 3.5% of GDP), OKP expenditure rises only half as much by 2045 (+0.8% vs. +1.5% 
of GDP, see Table 4). The latter is attributable to the fact that the proportion of dynamically 
developing long-term care expenditure is much lower for OKP (9%) than it is for the general 
government (23%) in the reference year 2013.  
 
Table 4: OKP vs. total and general government expenditure on healthcare (in % of GDP) 
 
 
When viewed by area, the lion's share of the rise in expenditure in OKP by 2045, or +0.5% of 
GDP, is attributable to the HeL area. The remaining increase of +0.3% of GDP is accounted 
for by long-term care from the age of 65. 
 
Due to the high proportion of expenditure on healthcare excluding long-term care, OKP 
expenditure reacts very sensitively to changes in assumptions regarding the Baumol effect and 
other non-demographic cost drivers such as advances in medical technology (see Figure 15). 
2013
Quote Quote Differenz
2013-30
Quote Differenz
2013-45
10.8 12.2 +1.4 14.0 +3.2
3.5 4.2 +0.7 5.0 +1.5
3.3 3.7 +0.4 4.1 +0.8
8.6 9.3 +0.7 9.9 +1.3
2.4 2.7 +0.4 3.0 +0.6
2.9 3.1 +0.2 3.4 +0.5
1.6 2.3 +0.7 3.4 +1.8
0.8 1.2 +0.4 1.7 +0.9
0.3 0.4 +0.1 0.6 +0.3
   Staat (inkl. Sozialversicherungen)
   OKP
Langzeitpflege ab 65 Jahren
   Staat (inkl. Sozialversicherungen)
   OKP
2045
Gesamte Gesundheit
   Staat (inkl. Sozialversicherungen)
   OKP
Gesundheit ohne Langzeitpflege
2030
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The stronger the Baumol effect in the HeL area, the higher the rise in expenditure vis-à-vis the 
"Reference scenario". Accordingly, the increase in OKP expenditure in the "Expanded Baumol" 
scenario is 0.7% of GDP higher than in the "Reference scenario", while in the "Baumol" 
scenario it is 0.5% of GDP higher than in the "Reference scenario".  
 
Figure 15: OKP expenditure in various scenarios (in % of GDP) 
 
 
Higher pressure on costs, as would be the case as a result of advances in medical technology 
("Cost pressure" scenario), for example, leads to a rise in expenditure of 0.3% of GDP. 
Expenditure rises similarly strongly if the assumptions regarding the development of the 
population's state of health and its need for care ("Pure ageing") are more pessimistic. The 
assumed morbidity development in the "Healthy ageing" scenario has an impact on the 
projections of a similar magnitude as in the "Pure ageing" scenario, but in this case it has a 
cost-restraining impact.  
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7. Comparison with other studies 
First of all, a brief comparison is made with the development scenarios in healthcare (Section 
7.1) dating back to 2012. Then a comparison is drawn with the work undertaken in this area 
by the OECD (Section 7.2) and the European Union (Section 7.3).  
 
7.1. Expenditure projections for healthcare in 2012 
A comparison with the results of the second expenditure projections undertaken as part of the 
2012 development scenarios shows that demographic pressure on healthcare expenditure is 
persisting.19 As in those earlier projections, the greatest pressure on expenditure generally and 
on the public finances in particular comes from the long-term care area. The breakdown by 
source of financing likewise reveals a very similar picture. As in the 2012 projections, the same 
assumptions are made in the current "Reference scenario" regarding non-demographic cost 
drivers (income elasticity of 1.1 in HeL, and the full Baumol effect in LTC). The resulting picture 
and the degree of dynamism evident are similar. In the current projections, total healthcare 
expenditure in the "Reference scenario" rises by 3.2% of GDP – from 10.8% (2013) to 14% 
(2045). For a comparable project timeframe of 32 years, the "Reference scenario" of the last 
expenditure projections likewise produces a rise of 3.2% of GDP – from 11.3% (2009) to 14.5% 
(2041).  
 
For this comparison, it should be borne in mind that a comprehensive adjustment of 
Switzerland's national accounting system took place in 2014, which has had an impact on 
healthcare expenditure as a proportion of GDP in the base year. The changeover in national 
accounting to the European System of Accounts (ESA 2010) resulted in a one-off rise of 5.7% 
in the level of Swiss GDP. As a result, expenditure on healthcare as a percentage of GDP 
declined in the base year. Prior to the revision, a value of 11.3% of GDP was arrived at for total 
healthcare expenditure for the base year (2009) in the last edition of the expenditure 
projections. As a result of the revision, the equivalent 2009 figure was reduced to 10.4% of 
GDP (FSO 2016). In addition to these statistical adjustments, two further differences should 
be taken into account. On the one hand, the projection period was shortened from 2016 to 
2045, while on the other the underlying estimate of future economic growth (1.5% versus 1.1% 
real p.a.) is more optimistic than in the last projections as a result of the assumption of higher 
gains in productivity and higher net immigration. With a higher level of labour productivity for 
the economy as a whole and the assumption of no productivity gains in LTC, the relative rise 
in costs works out greater in LTC as the full Baumol effect is felt. The assumed higher net 
immigration slightly restrains the age-related rise in expenditure as a result of the immigration 
                                               
19 The 2012 development scenarios were drawn up as part of the Legislature Financial Plan 2012-2015 (Federal 
Council 2012). For a detailed illustration, see Colombier (2012). 
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of predominantly working-age persons and the corresponding impact on the age cohorts – 
particularly in LTC.20 By contrast, in the last projections the rise in expenditure was more 
attributable to the assumed lower net immigration rate (more pronounced ageing) and less to 
the Baumol effect (lower productivity gains). 
 
7.2. Expenditure projections of the OECD 
De la Maisonneuve and Oliviera Martins (2014) present healthcare expenditure projections for 
OECD member states, and therefore for Switzerland too. The authors select a projection end 
date of 2060. An average of the years 2006-2010 is used as the base year. Here too, a 
distinction is made between the areas of HeL and LTC. By way of deviation from the 
presentation of the projections of this Working Paper, OKP expenditure – which is offered by 
private insurers in Switzerland – is assigned to public healthcare expenditure for purposes of 
better international comparability.  
 
Where public expenditure on total healthcare is concerned (government and OKP, HeL, LTC), 
the projections of the OECD work out higher than those contained in this Working Paper. For 
example, the OECD shows a rise in public expenditure from 6.9% (average of years 2006-
2010) to 8.8% of GDP for 2030 in the basic scenario ("Cost containment" scenario), in which 
it is assumed that political measures are taken to combat the high rise in healthcare 
expenditure over the projection period.21 In the OECD's second basic scenario ("Cost 
pressure"), in which no political countermeasures are assumed, the rise works out at 9.5% of 
GDP for the year 2030. By contrast, the projections in this Working Paper only show a rise 
from 6.8% of GDP in 2013 to 7.9% of GDP by 2034 for the government and OKP combined 
(see Table A.2). Whereas the OECD's projections of public expenditure on long-term care are 
very similar to the projections of this Working Paper, the OECD projects a stronger rise in 
expenditure in the HeL area.  
 
The reasons for these upward deviations are the more pessimistic assumptions regarding 
demographic development together with the selection of different base years. In addition, 
differences in the respective projection methodologies should also be noted. A key aspect here 
is the modelling of advances in medical technology: In the projections of this Working Paper, 
                                               
20 With regard to the development of the Swiss hospital and care market, the existing body of literature has been 
expanded recently by two Credit Suisse studies (Credit Suisse, 2013 & 2015). Although not the focus of analysis, 
the studies also touch on the question of how healthcare expenditure will develop in these two specific healthcare 
areas, particularly against a backdrop of an ageing society. An interesting complementary aspect of these studies 
is their appraisal of future regional disparities. A study co-authored by UBS and the Research Center for 
Generational Contracts of the University of Freiburg im Breisgau (Moog et al. 2014) presents a set of generational 
accounts for the Swiss public finances. This study also makes reference to implied government debt in the area of 
healthcare and long-term care, i.e. the extent of service requirements that are not covered by existing financing.  
21The comparison is restricted to the year 2030 as the OECD does not present any results for the year 2045.  
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advances in medical technology are captured indirectly through income elasticity (1.1 in the 
"Reference scenario" for HeL, 1.4 in the "Cost pressure" scenario for HeL), and are therefore 
tied to projected economic development. By contrast, the OECD applies a residual approach, 
in which the unexplained proportion of empirical analysis of healthcare expenditure for OECD 
countries is assigned to advances in medical technology and other supply-side factors.22 This 
residual expenditure growth (which works out at 1.7% on average) is assumed to be either 
constant for the projection period ("Cost pressure" scenario) or converging towards zero ("Cost 
containment" scenario), and is independent of economic development. For the HeL area, this 
contributes to a much higher rise in expenditure. A further difference lies in the hypothesised 
change in morbidity: The OECD assumes a "Healthy ageing" scenario, whereas the projections 
of this Working Paper assume a combination of "Pure ageing" and "Healthy ageing". 
7.3. Expenditure projections of the European Union 
The Ageing Working Group of the European Commission and the Economic Policy Committee 
(AWG) investigates at regular intervals how the ageing of the population influences 
demographic-dependent government expenditure. In its most recent projections (AWG 2015), 
the AWG likewise takes 2013 as its base year and projects expenditure development up to 
2060. The projections of this Working Paper lean heavily on the work of the Ageing Working 
Group with respect to the selected methodological approach, as well as with regard to 
modelling and the selection of scenarios. For example, the assumptions made in the 
"Reference scenario" regarding morbidity development and hypothesised income elasticity 
(1.1, or 1.4 in the "Cost pressure" scenario) are based on the work of the EU, particularly the 
AWG "Reference scenario" and the AWG risk scenario.23  
 
With regard to hypothesised demographic developments, both the EU and Switzerland exhibit 
a strongly ageing population structure. As in Switzerland, the proportion of people over 80 
relative to the total population rises in the EU from 5.1% in the base year to 10.1% in the year 
2045. In the base year of 2013, the proportion of people over 65 relative to the working-age 
population amounts to 30% on average in the EU and 28.5% in Switzerland. According to the 
demographic scenarios, by 2045 the average EU old-age dependency ratio is assumed to be 
53%, versus 48% in Switzerland. Potential economic growth in the EU as a whole is assumed 
to be relatively stable in the long term, and is very much compatible with the developments 
assumed in these projections. Estimated economic growth in the EU amounts to 1.4% for the 
                                               
22 On the basis of the results of empirical analysis for the OECD countries, the OECD assumes an income elasticity 
of 0.8 for healthcare expenditure.  
23 However, when extrapolating expenditure on long-term care, the EU projections take into account the probability 
of needing care (dependency ratio). That said, the projection results should not differ from one another (if all other 
assumptions remain the same) if the expenditure per dependent over the project period is not influenced by a 
change in dependency ratios. The concordance of the results of Weaver et al. (2008) and Colombier and Weber 
(2008) for the Swiss case suggest that this latter prerequisite is met.  
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projection timeframe up to 2045, whereas in Switzerland annual average growth is expected 
to come in at 1.5%. 
 
According to the projections of the EU, public expenditure on healthcare and long-term care 
rises by 1.7% of GDP by 2045 not just in the EU as a whole, but also in the eurozone, which 
is likely to be better for comparability purposes. The growth in expenditure for the public sector 
in Switzerland, which amounts to just over 1.5% of GDP, would therefore be below average 
(see Figure 16). However, if the rise in OKP expenditure is added to the public sector 
expenditure for purposes of better comparability (+0.5 GDP % HeL and +0.3 GDP % LTC), 
Switzerland exhibits a rise in expenditure of 2.4% of GDP, which is higher than the average 
and indeed higher than Germany (+1.9 GDP %), and puts Switzerland between Austria +2.1%) 
and Denmark (+2.5 GP %).24 
 
Where the comparison is concerned, it should be noted that the projections for the 
demographic and economic development of individual countries differ in some cases. For 50% 
of EU countries (including Germany), it is assumed that the population in 2060 will be smaller 
than in 2013, whereas it is assumed that the population will rise in the remaining countries. 
Other differences can be found in respect of the level of healthcare expenditure in the base 
year, the expenditure profiles, and institutional regulations for national healthcare systems (e.g. 
special financing regimes). For example, it should be factored into calculations that the 
proportion of healthcare expenditure which is directly paid by households or offset via private 
supplementary insurance is much higher in Switzerland in the base year (37%) than it is for 
the EU average (approximately 20%). Moreover, it should also be noted that this Working 
Paper assumes a constant income elasticity of 1.1 for the HeL area, whereas in the EU's 
projections the AWG reference and risk scenarios assume that the elasticities of 1.1 and 1.4 
respectively in the base year converge towards 1.0 by 2060. For the area of long-term care, it 
is assumed in the AWG scenarios that only a proportion of services is subject to increased 
cost pressure in the form of Baumol's cost disease. These two deviating assumptions result in 
comparatively lower increases in expenditure in the EU projections. 
 
Figure 16: Increase in public expenditure on healthcare and long-term care in an 
international comparison, 2013-2045 (in GDP %) 
                                               
24 In contrast to other European countries, mandatory health insurance is offered by private insurers in Switzerland, 
and is therefore not assigned to the general government sector. 
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Note: *including mandatory health insurance expenditure. 
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8. Conclusions for healthcare policy 
The projections of this Working Paper show that demographic change will exercise a significant 
influence on the dynamism of healthcare expenditure, thereby confirming the results of 
predecessor studies (Colombier 2012; Colombier and Weber 2008). The effect of an ageing 
population is most significant in the area of long-term care (from the age of 65). For healthcare 
excluding long-term care, non-demographic cost drivers – such as the Baumol effect and 
determinants captured indirectly by income elasticity such as advances in medical progress 
and market failures as a result of asymmetric information – are likewise very significant. As the 
key player in this area, (acting not just as regulator, but also as a source of financing and 
service provider), it is the cantons that will have to bear the main burden of rising healthcare 
expenditure. In addition, the public sector will be more heavily affected by an ageing population 
than OKP, as the government spends a greater proportion of its funds on long-term care (from 
the age of 65) than OKP.  
 
The projections provide the following pointers for the orientation of healthcare policy. On the 
one hand, measures should be promoted that sustainably alleviate the illness burden on the 
population, particularly in the case of chronic conditions, thereby facilitating healthy ageing. On 
the other hand, existing efficiency reserves need to be better exploited by avoiding 
unnecessary treatments, incorporating cost-benefit considerations more strongly into the 
design of the OKP service catalogue, and ensuring that the increasing productivity of medical 
services is appropriately reflected in the corresponding prices and tariffs. Finally, measures 
that counteract Baumol's cost disease – such as forward-looking staff planning and improved 
working processes – will also prove beneficial. 
 
Preventive measures and the strengthening of the population's own healthcare competencies 
can make a significant contribution to the avoidance of chronic conditions. Treating the five 
most frequent non-contagious illnesses (cardiovascular disease, diabetes, cancer, respiratory 
problems, and disorders of the musculoskeletal system) accounts for around 40% of direct 
healthcare costs in Switzerland. If one additionally adds psychiatric disorders and dementia, 
this figure rises to around 51% of all healthcare expenditure. According to the World Health 
Organization, some 50% of non-contagious chronic conditions could be prevented or at least 
delayed through a healthy lifestyle. The focus accordingly is on preventive measures that 
promote healthy nutritional and mobility behaviour, as well as a reduction in consumption of 
addictive substances (particularly alcohol and tobacco). Special offers for older people –for 
example, measures to prevent falls such as movement therapies – help to reduce the number 
of typically age-related accidents such as femoral neck fractures, and thereby reduce the 
number of hospitalisations. Movement therapies can additionally help older people to live 
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independently for longer, thereby postponing their admission to a care home and reducing the 
length of their stay in such an institution. From the financing perspective, preventive measures 
would have a greater cost-restraining impact for the public sector than they would for OKP, as 
a result of the relatively high proportion spent by the public sector on long-term care (from the 
age of 65) in comparison to OKP (23% vs. 9%).  
 
In the area of long-term care (from the age of 65), strengthening outpatient care as opposed 
to inpatient care (combined with measures to relieve the burden on caring relatives) would help 
to reduce costs, given the much lower costs of Spitex when it comes to caring for dependents. 
The focus here should be above all on improving the compatibility of working life and family 
care (e.g. through care leave). This would also deliver major efficiency gains, as, according to 
Federal Office of Public Health (FOPH), care homes are overused. This means that although 
ambulatory care would suffice for a substantial share of dependent elderly, they are admitted 
to care homes. In view of the large number of financing systems at work in the long-term care 
area (from the age of 65) – namely OKP, the cantons, AHV supplementary benefits, AHV 
allowance for the helpless, private households – a bundling of financing in a single source, e.g. 
in the form of care insurance, could facilitate better cost management and clearer 
responsibilities in this area.25 
 
While the hospital financing reform of 2012 – which had the transition from daily flat-rate costs 
to diagnosis-related costs at its core – improved incentives to increase efficiency in the 
inpatient area, fee-for-service remuneration remains the rule in the outpatient area. Such a 
model contains an inherent incentive to expand volumes. In particular, the obsolete TARMED 
tariff in outpatient medical services does not take sufficient account of technological advances, 
which means too high a valuation is placed on technical services in many cases. A dynamic 
adjustment mechanism linking such tariffs to advances in medical technology could restrain 
dynamism on both the volume and the cost side. 
 
Furthermore, a systematic review of healthcare technologies (medical procedures, 
medications, therapies) with a view to establishing their cost-benefit ratios (health technology 
assessment) could help to increase the efficiency of healthcare supply. For example, inefficient 
and ineffective procedures, medications and therapies are not systematically identified under 
the current system, and are therefore not excluded from OKP.  
 
                                               
25 In a recently published postulate report, the Federal Council discusses various options for a reform of care 
financing, including the introduction of mandatory care insurance (Federal Council 2016).  
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A study produced by the Swiss Health Observatory suggests that Switzerland will have a 
significant personnel requirement by 2030 as a result of demographic change and the ageing 
of existing health care personnel (Jaccard et al. 2009).26 The high level of turnover of staff in 
the healthcare industry and a parallel demographic development in neighbouring European 
countries is likely to compound this problem further. For that reason, forward-looking personnel 
planning and the corresponding training of a sufficient number of healthcare professionals will 
be needed if costs are to be contained and the level of supply maintained. In the absence of 
such measures, the inevitable consequence would be additional wage pressure – which would 
only be intensified by the Baumol effect in healthcare – and a rationing of services as a result 
of staff scarcity. 
  
                                               
26 According to this study, some 120,000 to 190,000 persons will have to be recruited by 2030. Around a third of 
this figure is attributable to the additional requirement for health and care services as a result of the increasing 
ageing of the Swiss population. However, Jaccard et al. (2009) rely on older demographic scenarios of the FSO in 
which a lower level of net immigration is assumed.  
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Table annex 
Table A1: Key figures for population and economic growth     
    2015 2030 2045 
Key figures for population growth in        
the FSO's reference scenario (A-00-2015)       
Total permanent residential population (m) 8 339.5 9 541.5 10 176.1 
    Balance of migration (net positive migration)   80 000 60 000 30 000 
Balance of migration in migration  
         scenario*   
90 000 80 000 40 000 
Average number of children per woman 1.51 1.56 1.58 
Life expectancy at birth          
Men   81.2 84.2 86.2 
Women   85.1 87.6 89.4 
Old-age dependency ratio**   29.1% 39.6% 48.1% 
 Youth ratio   32.3% 34.3% 33.9% 
Real old-age dependency ratio***   36.1% 48.3% 58.2% 
Labour force participation rate, 15 to 64-year-olds 84.0% 83.7% 83.9% 
Working-age population in full-time equivalents ('000) 4158.0 4500.0 4626.0 
          
Economic growth     2020-2045****   
          
    Labour productivity growth rate     1.2%   
    Average growth rate of working-age population   0.3%   
    Real interest rate (long term)     1.5%   
    Inflation     1.0%   
Nominal interest rate (real interest rate + inflation)   2.5%   
          
* As a result of the adjusted balance of migration in the "Migration" scenario (A-06-2015), other key figures also 
change relative to the "Reference scenario", such as the residential population and working-age population, for 
example. The average growth of the working-age population in the "Migration" scenario amounts to 0.5%, for 
example. For a detailed illustration, see FSO (2015a). 
** Old-age dependency ratio: Number of people over 65 relative to the working-age population. 
*** Real old-age dependency ratio: Number of people over 65 relative to the labour force (FTEs). 
**** Previously the key figures of the Legislature Financial Plan applied (see Long-Term Report on Sustainability 
2016, section 2).  
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* AHV/IV allowance for the helpless, AHV/IV contributions to medical services and therapeutic equipment. 
** Without participation of the public sector in the form of individual premium reduction, which is assigned to the 
general government sector.         
*** "Other expenditure" includes the expenditure of private households, mandatory accident insurance (SUVA and 
military insurance), as well as supplementary insurance, private foundations, and IV supplementary benefits, which 
are not affected by demographic ageing.    
**** OKP cost contribution and out-of-pocket payments (OOP). Cost contributions extrapolated on the basis of OKP 
expenditure projections. An approximation for the basis of the extrapolation of OOP was the breakdown of 
expenditure from 2013, i.e. 34% for outpatient healthcare excluding long-term care, 19% for inpatient long-term 
care, while the residual expenditure was extrapolated on the basis of GDP (particularly dental care treatment). 
          
The residual category in total healthcare is expenditure on long-term care below the age of 65.  
    
  
Tabelle A2: Ausgaben für das Gesundheitswesen im Referenzszenario nach Bereichen und Finanzierungsträgern in BIP-%
Ebene 2013
Gesamtes Gesundheitswesen 10.8 12.2 +1.4 14.0 +3.2
Gesundheit ohne Langzeitpflege 8.6 9.3 +0.7 9.9 +1.3
Langzeitpflege (ab 65 Jahren) 1.6 2.3 +0.7 3.4 +1.8
Finanzierungsträger
Staat (inkl. Sozialwerke) 3.5 4.2 +0.7 5.0 +1.5
Bund 0.4 0.5 +0.1 0.5 +0.1
Kantone 2.4 2.9 +0.5 3.5 +1.1
Gemeinden 0.3 0.4 +0.1 0.5 +0.2
AHV/ IV* 0.4 0.3 -0.0 0.4 +0.0
Gesundheit ohne Langzeitpflege 2.4 2.7 +0.4 3.0 +0.6
Bund 0.4 0.5 +0.1 0.5 +0.1
Kantone 1.9 2.1 +0.3 2.3 +0.5
Gemeinden 0.1 0.1 +0.0 0.1 +0.0
Langzeitpflege (ab 65 Jahren) 0.8 1.2 +0.4 1.7 +0.9
Bund - - -
Kantone 0.5 0.8 +0.2 1.1 +0.6
Gemeinden 0.2 0.3 +0.1 0.4 +0.2
AHV-HE 0.1 0.1 +0.0 0.2 +0.1
Obligatorische Krankenpflegeversicherung (OKP 3.3 3.7 +0.4 4.1 +0.8
Gesundheit ohne Langzeitpflege 2.9 3.1 +0.2 3.4 +0.5
Langzeitpflege (ab 65 Jahren) 0.3 0.4 +0.1 0.6 +0.3
Restliche Ausgaben*** 4.0 4.3 +0.3 4.8 +0.9
davon: private Haushalte**** 2.6 2.9 +0.3 3.3 +0.7
Niveau
2030 2045
Niveau
Veränderung 
2013-2030
Veränderung 
2013-2045
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Appendix  
 
Formal illustration of projection methodology 
The projections of expenditure per capita of age cohort y for year t can be illustrated by the 
following equation, which is the underlying formula for the expenditure projections. 
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whereby: 
 t= 1,....,32 and 0:= base year. 
 E(t,j):= expenditure (nominal) on healthcare excluding long-term care or long-term care 
(from the age of 65) per capita of age cohort j in year t, in each case divided between 
men and women. 
 Pop(t,j):= number of men or women of age cohort j in year t according to FSO 
demographic scenario A-00-2015 or A-06-2015. 
 Morbidity parameter: additional period of life of age cohort j in a better state of health 
(morbidity rate) in year t compared to age cohort j in the base year.  
o τ(t,j): number of years in better state of health. 
o λ(t,j): period of less than one year spent in better state of health measured in 
months. 
o For the area of healthcare excluding-long-term care, an improvement in the 
state of health is assumed from the age of 41, j>41, and for long-term care (on 
those over 65) from the age of 66, j>65.  
 y(i):= growth rate of real GDP per capita in year i, i≤t. 
 1+η(i):= "income elasticity" in year i, η(i)≥0, i≤t. 
 π:= long-term rate of inflation. 
 ω:= long-term growth rate of average annual real wages. 
 μ:= Baumol parameter; μ=1: full Baumol effect, i.e. no productivity gains in health care; 
μ=0: no Baumol effect. 
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The right-hand side of the basic formula (A1.1) can be understood as follows: 
 The first coefficient describes the correlation between an increase in life expectancy 
and the change in morbidity of an age cohort j in year t. Here it is a assumed that with 
an increase in life expectancy there is a change vis-à-vis the base year in the probability 
of falling ill or requiring care at a given age. Let us assume that the life expectancy of 
50-year-old women in 2045 is 1 year and 8 months higher than in the base year 2013, 
and that 50-year-old women spend these additional years of life in a better state of 
health than 50-year-old women in the base year ("Healthy ageing" scenario). For the 
sake of simplicity, we can then assume that 50-year-old women in 2045 are in the same 
state of health as women who are 1 year and 8 months younger in the base year, i.e. 
women aged 48 years and 4 months. The morbidity parameter accordingly equates to 
(32, 50)=1.27 As only annual data is available for expenditure per capita, the annual 
expenditure for the age cohorts of 48-year-old and 49-year-old women in the base year 
have to be weighted with the number of months. In this example, λ(32, 50) equals eight. 
There has been a de facto shift of the expenditure profile in year t to the right compared 
to the base year (cf. Figure 2). This approach is selected for all age cohorts of 41 and 
upwards in the case of healthcare excluding long-term care, and for all age cohorts of 
65 and upwards in the case of long-term care.  
 The second coefficient describes the demand-side and supply-side effects triggered 
by the increase in national income, which are only assumed to have an impact on 
healthcare expenditure excluding long-term care. If η>0, it is assumed that an increase 
in real GDP per capita has a disproportionate impact on the expenditure per capita of 
an age cohort. As expenditure per capita is given in nominal amounts, the inflation rate 
π likewise has to be taken into account. In both cases, the expenditure profile in a given 
year t shifts upward compared to the expenditure profile of the base year (see Figure 
2). 
 The third coefficient captures the Baumol effect, which is a supply-side effect. For the 
Baumol effect it is assumed that (real) wage growth in healthcare (or in a sub-area of 
healthcare) is in step with wage growth in the overall economy. Furthermore, average 
real wage growth in the real economy corresponds to advances in productivity. If no 
productivity advances are achieved in healthcare, the Baumol effect is felt in full, and μ 
is equal to one. Wage growth then feeds through fully into a price effect, leading to an 
above-average rate of inflation in healthcare. If 0< μ <1, the Baumol effect can be 
described as partial, whereby although there are productivity advances in healthcare, 
these are less pronounced than for the overall economy. In other words, wage growth 
is not fully transferred to prices. 
                                               
27 As the base year is 2013 (t=0), t=32 is equivalent to 2045.  
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After ascertaining the expenditure per capita of an age cohort j for each year t, total expenditure 
is then calculated for year t. In order to determine total expenditure, the expenditure per capita 
of an age cohort is initially multiplied by the population size of the corresponding age cohort 
and then aggregated across all age cohorts (c.f. equation (A1.2)). This is done separately for 
men and women before then arriving at total healthcare expenditure. 
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